Related Experiment Video

Updated: Jun 21, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K

Challenges and practical considerations in the management of blastic plasmacytoid dendritic cell neoplasm: A

Haripriya Andanamala1, Naveen Pemmaraju2, Taha Al-Juhaishi1

  • 1OU Stephenson Cancer Center, Oklahoma City, OK, United States.

Leukemia Research Reports
|November 20, 2024
PubMed

Insights

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare hematologic malignancy with poor outcomes. This study reviews five BPDCN cases treated since TAG approval, highlighting treatment challenges.

Area of Science:

  • Hematology
  • Oncology
  • Rare Cancers

Background:

  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare, aggressive hematologic malignancy.
  • BPDCN frequently metastasizes to the skin, lymph nodes, CNS, and bone marrow.
  • Limited prospective studies contribute to poor outcomes, with median survival of 9-23 months.

Observation:

  • This study details the treatment experience of five consecutive BPDCN patients.
  • Treatment was administered following the approval of TAG (tagraxofusp).
  • The study focuses on challenges in managing BPDCN due to its rarity and aggressive nature.

Findings:

  • The study presents a case series of BPDCN patients treated with TAG.
  • Challenges in diagnosis and treatment of BPDCN are discussed.
  • Limited effective therapies and provider experience impact patient outcomes.

Implications:

  • This case series provides insights into managing BPDCN with TAG.
  • Understanding treatment challenges is crucial for improving outcomes in rare hematologic malignancies.
  • Further research is needed to establish effective therapeutic strategies for BPDCN.

Keywords:
BPDCNCase seriesRare cancersStem cell transplantationTargeted therapy

More Related Videos

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.3K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...